Beyond resistance: optimizing CAR-T sequencing following bispecific antibody failure in DLBCL

This journal article was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

This journal article was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

What the study was

Study design

Journal article

Maturity

Exploratory

Journal

Journal of translational medicine

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.